Masataka Haneda

1.0k total citations
29 papers, 804 citations indexed

About

Masataka Haneda is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Masataka Haneda has authored 29 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Masataka Haneda's work include Renal Transplantation Outcomes and Treatments (5 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Masataka Haneda is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Masataka Haneda collaborates with scholars based in Japan, Italy and Greece. Masataka Haneda's co-authors include Ken‐ichi Isobe, Tadao Hasegawa, Eiji Kojima, Takaaki Kobayashi, Makoto Sawada, Sachiko Ito, Kaoru Shimokata, Kenta Iwasaki, Yoshiyuki Ishida and Yuko Miwa and has published in prestigious journals such as Journal of Virology, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Masataka Haneda

28 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Haneda Japan 15 357 199 196 135 126 29 804
Xinhui Sun China 9 491 1.4× 50 0.3× 272 1.4× 60 0.4× 23 0.2× 22 961
Anouk Emadali France 15 393 1.1× 245 1.2× 105 0.5× 76 0.6× 141 1.1× 25 678
Anne Houllier France 14 335 0.9× 71 0.4× 146 0.7× 385 2.9× 53 0.4× 19 1.0k
Christine Maeder Switzerland 12 417 1.2× 113 0.6× 100 0.5× 72 0.5× 158 1.3× 19 661
Sophie Foppolo France 10 289 0.8× 48 0.2× 43 0.2× 58 0.4× 39 0.3× 17 672
Mireille Riedinger United States 14 435 1.2× 60 0.3× 73 0.4× 535 4.0× 68 0.5× 16 1.0k
Yoshio Yazaki Japan 15 483 1.4× 139 0.7× 125 0.6× 171 1.3× 77 0.6× 26 912
Peter L.J. de Keizer Netherlands 15 719 2.0× 86 0.4× 43 0.2× 173 1.3× 80 0.6× 24 1.1k
Hye‐Sook Kwon United States 12 423 1.2× 32 0.2× 40 0.2× 395 2.9× 141 1.1× 25 1.1k
Meng-Yun Chou United States 7 221 0.6× 132 0.7× 78 0.4× 540 4.0× 152 1.2× 7 923

Countries citing papers authored by Masataka Haneda

Since Specialization
Citations

This map shows the geographic impact of Masataka Haneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Haneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Haneda more than expected).

Fields of papers citing papers by Masataka Haneda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Haneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Haneda. The network helps show where Masataka Haneda may publish in the future.

Co-authorship network of co-authors of Masataka Haneda

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Haneda. A scholar is included among the top collaborators of Masataka Haneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Haneda. Masataka Haneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haneda, Masataka, Katsuhiro Masago, Shiro Fujita, et al.. (2020). Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF. Pathology International. 70(5). 253–261. 13 indexed citations
3.
Masago, Katsuhiro, Shiro Fujita, Masataka Haneda, et al.. (2020). Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients. Thoracic Cancer. 11(7). 1827–1834. 6 indexed citations
4.
Miwa, Yuko, Masaki Iwamoto, Shunichi Suzuki, et al.. (2015). Functional Difference Between Membrane-bound and Soluble Human Thrombomodulin. Transplantation. 99(4). 702–709. 9 indexed citations
5.
6.
Kuzuya, Takafumi, Yuko Miwa, Kenta Iwasaki, et al.. (2014). Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation. International Immunopharmacology. 22(2). 384–391. 7 indexed citations
7.
Iwamoto, Masaki, Akira Ōnishi, Yuko Miwa, et al.. (2012). Production of cloned pigs expressing human thrombomodulin in endothelial cells. Xenotransplantation. 19(2). 82–91. 23 indexed citations
8.
Saka, Yosuke, Kazuhiro Furuhashi, Takayuki Katsuno, et al.. (2011). Adipose‐derived stromal cells cultured in a low‐serum medium, but not bone marrow‐derived stromal cells, impede xenoantibody production. Xenotransplantation. 18(3). 196–208. 24 indexed citations
9.
Miwa, Yuko, Koji Yamamoto, Akira Ōnishi, et al.. (2010). Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation. 17(1). 26–37. 51 indexed citations
10.
Iwase, Hayato, Takaaki Kobayashi, Yasuhiro Kodera, et al.. (2010). Clinical Significance of Regulatory T-Cell–Related Gene Expression in Peripheral Blood After Renal Transplantation. Transplantation. 91(2). 191–198. 33 indexed citations
11.
Iwasaki, Kenta, Yuko Miwa, Masataka Haneda, et al.. (2009). Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack. Biochemical and Biophysical Research Communications. 391(2). 1210–1215. 29 indexed citations
12.
Ito, Sachiko, Kenya Kimura, Masataka Haneda, et al.. (2007). Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-β stimulation via the PI3K/Akt pathway. Experimental Gerontology. 42(6). 532–537. 73 indexed citations
13.
Minami, Kahori, Yukihiro Tambe, Ryosuke Watanabe, et al.. (2007). Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway. Journal of Virology. 81(20). 11106–11115. 30 indexed citations
14.
Ito, Sachiko, Makoto Sawada, Masataka Haneda, Yoshiyuki Ishida, & Ken‐ichi Isobe. (2006). Amyloid-β peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neuroscience Research. 56(3). 294–299. 42 indexed citations
15.
Ito, Sachiko, Makoto Sawada, Masataka Haneda, et al.. (2005). Amyloid‐β peptides induce cell proliferation and macrophage colony‐stimulating factor expression via the PI3‐kinase/Akt pathway in cultured Ra2 microglial cells. FEBS Letters. 579(9). 1995–2000. 25 indexed citations
16.
Haneda, Masataka, et al.. (2004). Regulation of mouse GADD34 gene transcription after DNA damaging agent methylmethane sulfonate. Gene. 336(1). 139–146. 8 indexed citations
17.
Haneda, Masataka, Eiji Kojima, Akihiko Nishikimi, et al.. (2004). Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA‐damaging stress‐induced phospho‐serine 15 of p53. FEBS Letters. 567(2-3). 171–174. 36 indexed citations
18.
Hasegawa, Yoshinori, Hengyi Xiao, Masataka Haneda, et al.. (2003). GADD34 induces p53 phosphorylation and p21/WAF1 transcription. Journal of Cellular Biochemistry. 90(6). 1242–1249. 47 indexed citations
19.
Kojima, Eiji, Akihide Takeuchi, Masataka Haneda, et al.. (2003). The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress—elucidation by GADD34‐deficient mice. The FASEB Journal. 17(11). 1–18. 192 indexed citations
20.
Murata, Makoto, Tetsuya Nishida, Masataka Haneda, et al.. (1999). A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low‐dose immunosuppressant in allogeneic haemopoietic stem cell transplantation. British Journal of Haematology. 105(3). 799–802. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinhui Sun Breakdown of academic impact, for papers by Anouk Emadali Breakdown of academic impact, for papers by Anne Houllier Breakdown of academic impact, for papers by Christine Maeder Breakdown of academic impact, for papers by Sophie Foppolo Breakdown of academic impact, for papers by Mireille Riedinger Breakdown of academic impact, for papers by Yoshio Yazaki Breakdown of academic impact, for papers by Peter L.J. de Keizer Breakdown of academic impact, for papers by Hye‐Sook Kwon Breakdown of academic impact, for papers by Meng-Yun Chou
Rankless by CCL
2026